mybacs is a direct-to-consumer gut-health supplement company founded in 2019, now in heavy scaling mode. The hiring mix and active projects reveal a marketing-first growth strategy: 8 of 13 open roles sit in marketing, with active initiatives around performance marketing, cross-channel attribution, and subscription reactivation. The tech stack (Meta, Google Ads, Shopify, Klaviyo, Holistics) is standard DTC, but the pain-point pattern—scaling paid channels, unit economics, and CRM optimization—suggests they're hitting the ceiling of early-stage playbooks and building out more sophisticated attribution and retention infrastructure.
Notable leadership hires: Performance Marketing Head
mybacs manufactures synbiotic supplements (probiotic blends with prebiotics, minerals, and vitamins) formulated for individual microbiome needs. The company is Swiss-headquartered in Zug and operates as a privately held DTC brand selling through direct channels and Shopify. With 51–200 employees, the organization is weighted toward marketing and creative production (design, content, social materials), indicating a consumer brand focused on paid acquisition and brand-building. Current priorities include entering new geographic markets, reactivating dormant subscribers, and improving unit economics as the company moves beyond initial growth.
mybacs runs Meta, Instagram, Google Ads, Google Shopping, and Google Analytics 4 for paid media and analytics. CRM and email marketing flow through Shopify and Klaviyo. Design and content production uses Adobe Creative Cloud (InDesign, Photoshop, Illustrator, After Effects) and Figma.
Active projects include performance marketing strategy, cross-channel growth, attribution tracking, social media content, product packaging, subscription reactivation programs, and CRM optimization (forms, mailings, pop-ups). The company is also preparing for new market entry.
Other companies in the same industry, closest in size